Peer-reviewed veterinary case report
Eye inflammation after cataract surgery in dogs with two steroid
By Palmer-Greenberg, Samantha V et al.·Published in Veterinary ophthalmology·2026·Animal Eye Care, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Comparison of Postoperative Intraocular Inflammation in Dogs Receiving Transzonular Intravitreal Triamcinolone-Moxifloxacin Versus Subconjunctival Triamcinolone After Phacoemulsification.
- Species:
- dog
Plain-English summary
A group of 48 dogs undergoing cataract surgery received two different treatments to reduce inflammation: one eye was treated with a combination of triamcinolone and moxifloxacin injected into the eye, while the other eye received triamcinolone injected under the conjunctiva. After surgery, both treatments showed similar effectiveness in managing inflammation and maintaining normal eye pressure. Although the injected medication in the eye showed slightly more inflammation at one point, overall, both methods were safe and effective for post-surgery care. The dogs did well, and both treatments are considered good options for managing inflammation after cataract surgery.
People also search for: dog cataract surgery recovery · eye inflammation treatment for dogs · triamcinolone for dogs after surgery
Abstract
OBJECTIVE: To evaluate the postoperative effect of transzonular intravitreal triamcinolone-moxifloxacin compared to subconjunctival triamcinolone administered during phacoemulsification in dogs. ANIMALS STUDIED: Forty-eight dogs (96 eyes) undergoing bilateral phacoemulsification and intraocular lens implantation. PROCEDURES: All dogs undergoing phacoemulsification and intraocular lens implantation received transzonular intravitreal triamcinolone-moxifloxacin (TITM) in one eye and subconjunctival triamcinolone (SCT) in the contralateral eye. Aqueous flare (AF), anterior chamber fibrin formation (FF), pigment precipitates (PP) on the intraocular lens, posterior capsular opacification (PCO), corneal edema (CE), and intraocular pressure (IOP) were assessed 1 day, 1 week, 2-3 weeks, 4-6 weeks, 8-12 weeks, and ≥ 3 months postoperatively. RESULTS: There was no difference in AF over time (p > 0.05); however, at 2-3 weeks postoperatively, the average AF was statistically greater (p = 0.01) in the TITM group compared to the SCT group. At three postoperative time points, IOP was significantly different (p < 0.05) between TITM and SCT eyes, but remained within a normal reference range. In both groups, IOP significantly decreased (p < 0.05) over time. CONCLUSIONS: In the parameters evaluated, including overall visual outcome and surgical success, no clinically relevant differences between groups were appreciable. TITM and SCT, used adjunctively to postoperative topical ophthalmic and oral anti-inflammatories, appear to be acceptable techniques for administering a local ocular corticosteroid during canine phacoemulsification, but whether they provide any synergistic or additive effect remains unclear.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40243332/